The abstract is read at the publisher; the summary is JClub's.
TXNIP enhances HIV-1 LTR-driven transcription, productive replication, and latency reversal, with EZH2-ETV1 repression controlling TXNIP expression in multiple cell and ex vivo models.
- Why it matters: Persistent HIV-1 latency limits durable remission, and the host mechanisms that govern proviral transcriptional competence and inducible reactivation are not fully defined.
- What they did: The study used TXNIP depletion or overexpression across reporter, productive-infection, chronically infected, latency, primary-cell, and ex vivo systems, plus ChIP/Co-IP to map TXNIP at LTR chromatin and within BRD4-, CDK9-, and Tat-containing complexes.
- The result: EZH2 perturbation reduced H3K27me3 at the ETV1 promoter, increased ETV1 and TXNIP promoter activity, and SRI-37330 suppressed replication and inducible reactivation in ART-suppressed ex vivo CD4+ T cells, with effects attenuated by TXNIP depletion.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.